Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $78.45 USD
Change Today +0.78 / 1.00%
Volume 407.7K
As of 8:10 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitleKey Developments
Stephen Sabba M.D. 11 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeLigand Announces SEC Investigation
09/12/05
David Knott 26 RelationshipsDirector and Member of Audit CommitteeLigand Pharmaceuticals Inc. announced delayed 10-Q filing
11/9/06
Sunil Patel 14 RelationshipsDirector and Member of Audit CommitteeLigand Pharmaceuticals Inc. announced delayed annual 10-K filing
03/16/06

Compensation Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitle
Jason Aryeh 25 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Todd Davis 19 RelationshipsDirector and Chairman of Compensation Committee
John LaMattina Ph.D. 89 RelationshipsDirector and Member of Compensation Committee
LGND Compensation vs. Industry
510.2K
395.8K
Chief Executive Officer
300.5K
283.8K
Chief Financial Officer
375.4K
359.5K
Chief Operating Officer
Share price activity for LIGAND PHARMACEUTICALS (LGND)
52 Week Price Performance
LGND
Industry Average

Nominating Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitleKey Developments
John Kozarich Ph.D. 47 RelationshipsChairman and Member of Nominating & Corporate Governance CommitteeLigand Pharmaceuticals Incorporated Announces Management Changes
02/2/15
Jason Aryeh 25 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeLigand Pharmaceuticals Incorporated Names Melanie J. Herman as Principal Accounting Officer
04/11/14
Stephen Sabba M.D. 11 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeLigand Pharmaceuticals Incorporated Announces Management Changes
02/11/14

Corporate Governance Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitle
Jason Aryeh 25 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
John Kozarich Ph.D. 47 RelationshipsDirector and Chairman of Compensation Committee
Stephen Sabba M.D. 11 RelationshipsDirector and Member of Compensation Committee
LGND and Competitor
Insiders vs. External
Board
11%
89%
Ligand Pharmaceuticals Incorporated
Insiders
External Board Members

Advisory Committee* - ligand pharmaceuticals (LGND)

Name (Board Relationships)/Title Board Affiliations
Shalendar Bhasin 8 Relationships
Scientific Advisor
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $78.45 USD +0.78

LGND Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LGND.
View Industry Companies
 

Industry Analysis

LGND

Industry Average

Valuation LGND Industry Range
Price/Earnings 100.0x
Price/Sales 23.9x
Price/Book 57.8x
Price/Cash Flow 126.9x
TEV/Sales 18.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.